Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

558
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
558
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.5K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

381
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
381
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

346
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
346
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

680
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
680
Anatomy of the Heart01:27

Anatomy of the Heart

120.6K
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
120.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of the VIRSTA and VIRSTA+ Scores to Identify Patients with Staphylococcus aureus Bacteremia at Very Low Risk of Infective Endocarditis.

Infectious diseases and therapy·2026
Same author

In vitro and in vivo activity of daptomycin plus ceftaroline for the treatment of experimental endocarditis due to Enterococcus faecalis with and without high-level aminoglycoside resistance.

The Journal of antimicrobial chemotherapy·2026
Same author

Warning indicators for heart transplantation requirement at the time of hypertrophic cardiomyopathy diagnosis.

Cardiology journal·2026
Same author

In vitro activity of amoxicillin combined with oral cephalosporins against endocarditis-associated E. faecalis clinical isolates.

The Journal of antimicrobial chemotherapy·2026
Same author

Transcatheter Mitral and Aortic Paravalvular Leak Closure: Innovations, Challenges, and Future Directions.

Circulation. Cardiovascular interventions·2026
Same author

False-Positive PET Uptake in Left Atrial Appendage Closure Devices Due to Postoperative Inflammatory Response.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Feb 13, 2026

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

16.8K

Valvular Heart Disease Epidemics.

Blanca Domenech, José Luis Pomar, Susanna Prat-González

    The Journal of Heart Valve Disease
    |March 6, 2018
    PubMed
    Summary

    Valvular heart disease (VHD) affects nearly a quarter of cardiovascular patients, increasing with age. Degenerative causes are most common, with over half requiring intervention, highlighting VHD as a significant public health issue.

    More Related Videos

    Isolation of Valvular Endothelial Cells
    11:04

    Isolation of Valvular Endothelial Cells

    Published on: December 29, 2010

    21.0K
    Implantation of Total Artificial Heart in Congenital Heart Disease
    07:27

    Implantation of Total Artificial Heart in Congenital Heart Disease

    Published on: July 18, 2014

    25.2K

    Related Experiment Videos

    Last Updated: Feb 13, 2026

    Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
    12:12

    Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

    Published on: February 14, 2017

    16.8K
    Isolation of Valvular Endothelial Cells
    11:04

    Isolation of Valvular Endothelial Cells

    Published on: December 29, 2010

    21.0K
    Implantation of Total Artificial Heart in Congenital Heart Disease
    07:27

    Implantation of Total Artificial Heart in Congenital Heart Disease

    Published on: July 18, 2014

    25.2K

    Area of Science:

    • Cardiology
    • Public Health
    • Epidemiology

    Background:

    • Valvular heart disease (VHD) represents a significant health burden, yet its full prevalence and impact remain underestimated.
    • Understanding VHD prevalence is crucial for healthcare planning and resource allocation.

    Purpose of the Study:

    • To determine the prevalence of VHD and its treatment patterns within a defined healthcare setting.
    • To provide data for optimizing the management of VHD.

    Main Methods:

    • Retrospective analysis of 1,935 adult patients assessed for cardiovascular disorders over six months in 2014.
    • Inclusion of both inpatient (cardiology, cardiac surgery, geriatrics) and outpatient populations.
    • Data collection on VHD epidemiology, etiology, echocardiography, and treatment.

    Main Results:

    • Moderate-to-severe VHD identified in 23.4% of patients, with prevalence rising with age.
    • Degenerative etiology accounted for 60% of VHD cases; mitral and aortic valve diseases were most common.
    • VHD represented 24.2% of cardiovascular admissions, with 55% requiring interventional treatment.

    Conclusions:

    • VHD is a prevalent condition, particularly in older adults, and constitutes a substantial portion of cardiovascular hospital admissions.
    • VHD poses a growing public health challenge, necessitating increased research, improved diagnostics, and effective treatment strategies.